GENEVA, Aug. 18 -- VERONA PHARMA PLC (One Central SquareCardiff CF10 1FS) filed a patent application (PCT/EP2025/052789) for "ENSIFENTRINE FOR THE TREATMENT OF COPD" on Feb 04, 2025. With publication no. WO/2025/168546, the details related to the patent application was published on Aug 14, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): RHEAULT, Tara Renae (c/o Verona Pharma PLCOne Central SquareCardiff CF10 1FS)
Abstract:
The present invention relates to a compound for use in a method of treating chronic obstructive pulmonary disease (COPD) in a patient suffering from COPD, which compoun...